Vladimir Kolesnichenko PhD

Vladimir Kolesnichenko PhD

Professor
  • Synthesis and     characterization of ultrasmall magnetic nanoparticles for biomedical     applications.
  • we are developing novel MRI imaging agents which be     selectively recognized by cancerous cells.  Their size and     amphiphilic properties will be optimized to avoid phagocytic and     early renal clearance, which will make them an effective tool for early     detection of cancer.  
  • National Taras Shevchenko University, Kyiv, Ukraine     (BS, MS); Institute of General and Inorganic Chemistry, Kyiv,     Ukraine (PhD); The University of Iowa (Postdoc)
  • ORCID: https://orcid.org/0000-0001-5497-7085
  • NCBI: https://www.ncbi.nlm.nih.gov/sites/myncbi/1hEVrJkxduZ5J/bibliography/48720938/public/?page=1
  • Selected publications: (a) Tenacic Acids: a New Class of Tenacious Binders to Metal Oxide Surfaces.  Rajesh Komati, Carl     Mitchell, Anastasia LaBeaud, Huy Do, Galina Goloverda and Vladimir     Kolesnichenko, Chemistry-A European Journal, 2018, 24, 14824-14829.      (b) A Versatile Method of Ambient-Temperature Solvent Removal. Igor     Kolesnichenko, Galina Goloverda and Vladimir Kolesnichenko, Organic     Process Research & Development, 2020, 24, 25-31.
  • Keywords: superparamagnetic nanoparticles, MRI contrast agents

LCRC Faculty

Mary Maluccio, MD, MPH, FACS
Translational Oncology
LSU Health - New Orleans
Tarun Mandal PhD
Translational Oncology
Xavier University
Elizabeth Martin, PhD
Cancer Biology
Tulane University School of Medicine
Marc Matrana MD
Translational Oncology
Ochsner Health
Michelle Matter PhD
Cancer Biology
Tulane University School of Medicine
Georgios Matthaiolampakis PhD
Translational Oncology
University of Louisiana Monroe
Yvette Bren Mattison, PhD
Translational Oncology
LSU Health - New Orleans
Harris McFerrin, PhD
Genes X Environment
Xavier University
Kacie Mennie, PhD
Population Sciences
Louisiana Tech University